Month: October 2016

Company: Oncolytics Biotech Inc. Symbol: TSX: ONC Length: 00:19:39 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in late stage …

Oncolytics Biotech – Development of Oncolytic Viruses Read More »

Company: DelMar Pharmaceuticals, Inc Symbol: NASDAQ: DMPI Length: 00:26:11 Presenter: Jeffrey Bacha, Chairman Occasion: Richmond Club Lunch, Toronto DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. Product Information The Company’s lead asset, VAL-083, is currently undergoing …

DelMar Pharmaceuticals Develops and Commercializes Proven Cancer Therapies Read More »

Company: Metalla Inc. Symbol: CSE: XBR, OTC: EXCFF, FRK: X9CN Length: 00:17:50 Presenter: Tim Gallagher, Chairman and CEO Occasion: Richmond Club Lunch, Toronto Metalla Inc. is a precious metals royalty and streaming company engaged in the acquisition and management of precious metal royalties, streams and similar production based interests. Head Office: Metalla Royalty and Streaming 8 King …

Metalla Acquires and Manages Precious Metal Royalties Read More »